1997
DOI: 10.1016/s0024-3205(97)01061-8
|View full text |Cite
|
Sign up to set email alerts
|

Drug Metabolizing Enzyme Activities and Superoxide Formation in Primary and Immortalized Rat Brain Endothelial Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
20
0

Year Published

2001
2001
2012
2012

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(21 citation statements)
references
References 38 publications
1
20
0
Order By: Relevance
“…Chat et al (1998) reported a similar level of activity for P450 related enzymes in microsomes prepared from rat primary microvascular cerebrovascular endothelial cells (CVEC) and CVEC that had been immortalized (RBE4). A study that used pieces of tissue excised from the blood brain barrier of rats localized the induced expression of CYP1A to the cerebral veins and arteries, with the only activity in capillary endothelium in the vessels in the choroid plexus (Granberg et al,2003) .…”
Section: Immunochemical Identification Of Cyp1amentioning
confidence: 89%
See 1 more Smart Citation
“…Chat et al (1998) reported a similar level of activity for P450 related enzymes in microsomes prepared from rat primary microvascular cerebrovascular endothelial cells (CVEC) and CVEC that had been immortalized (RBE4). A study that used pieces of tissue excised from the blood brain barrier of rats localized the induced expression of CYP1A to the cerebral veins and arteries, with the only activity in capillary endothelium in the vessels in the choroid plexus (Granberg et al,2003) .…”
Section: Immunochemical Identification Of Cyp1amentioning
confidence: 89%
“…Until now mammalian endothelial cell cultures have been the cells used for studies of the cellular response in the vascular system to exposure to AhR agonists (Farin et al,1994;Stegeman et al,1995;Celander et al,1997;Chat et al,1998;Thum et al,2000;Annas et al,2000b;Savouret et al,2001;Hennig et al,2002a;Borlak et al,2003;Ramadass et al,2003). Although most of the mammalian endothelial cells have been cultured from large vessels differential responses to AHR agonists have been reported, for example, between human umbilical artery vs umbilical vein cells, (Annas et al,2000b).…”
Section: Immunochemical Identification Of Cyp1amentioning
confidence: 99%
“…27 gamma-glutamyl transpeptidase (Beuckmann et al, 1995), alkaline phosphatase (Beuckmann et al, 1995), aromatic L-amino acid decarboxylase (Betz et al, 1980;Matter & Balda, 2003b), the phase I metabolising enzymes CYP1A1 (Filbrandt et al, 2004), CYP1B1 (Filbrandt et al, 2004), CYP3A4 (Ghosh et al, 2010;Ghosh et al, 2011), andCyp4x1 (AlAnizy et al, 2006), NADPH-CYP P450 reductase (Chat et al, 1998;Ghersi-Egea et al, 1988;Minn et al, 1991;Ravindranath et al, 1990), epoxide hydrolase (Ghersi-Egea et al, 1988;Minn et al, 1991), and the phase II enzymes, 1-naphthol-UDP-glucuronosyltransferase (Ghersi-Egea et al, 1988) and GSTμ (Shang et al, 2008), and GSTπ (Bauer et al, 2008;Shang et al, 2008). The presence of these enzymes in the brain microvasculature indicates the existence of a metabolic barrier.…”
Section: Blood-brain Barrier Anatomymentioning
confidence: 99%
“…En passage across the barrier and within the brain, drugs can undergo inactivation and elimination comparable to hepatic drug metabolism. In the brain, the following phase I enzymes have been identified: monoamine oxidases, CYP P450, NADPH-CYP P450 reductase, and epoxide hydrolases (Chat et al, 1998;Dutheil et al, 2010;Ghersi-Egea et al, 1998;Ghersi-Egea et al, 1988;Ghersi-Egea et al, 1993;Minn et al, 1991;Ravindranath et al, 1990). Phase II enzymes identified in the brain include UDP-glucuronosyltransferase (UGT), phenol sulfotransferase (PST), and GST (Dutheil et al, 2010;Ghersi-Egea et al, 1998;Ghersi-Egea et al, 1988;Ghersi-Egea et al, 1993;Minn et al, 1991).…”
Section: The Metabolic Blood-brain Barriermentioning
confidence: 99%
“…11) ROS produced by CYPs induce oxidative stress which causes various pathological conditions. [11][12][13] Some CYP family proteins, especially the CYP2C subfamily, are expressed in not only brain regions such as the cortex, hippocampus and basal ganglia, 14) but also in vascular endothelial cells, 15) thus suggesting the possibility that ROS derived from CYP result in numerous cerebral vascular disorders.…”
mentioning
confidence: 99%